MrMike
liked
Ocugen: Potential for major gains
Adria Cimino $Ocugen (OCGN.US)$ : Ocugen surged more than 700% in a matter of weeks earlier this year on optimism about potential coronavirus vaccine sales. The biotech company partnered with Bharat Biotech to co-commercialize that company's vaccine -- Covaxin -- in the U.S. The deal later expanded to include Canada. But Ocugen has struggled to actually bring Covaxin to market. As a result, shares have dropped 68% from their peak back in February.
Pfizer: Something to attract nearly every investor
Keith Speights $Pfizer (PFE.US)$ : If you're an income-seeking investor, Pfizer is a no-brainer choice over Ocugen. The big drugmaker's dividend currently yields 2.7%. It's a pretty safe bet that Pfizer will increase its dividends for years to come. Ocugen, of course, doesn't make enough money to pay a dividend.
Ocugen or Pfizer?
Your choice may depend on your investing style. An investor looking for a chance at steep gains fast may go for Ocugen. But as Keith says, the risk is that such a stock also may suffer big losses. Overall, Pfizer represents an opportunity to grow your investment over time -- and expose yourself to a lot less risk. In general, that's always a better recipe for long-term investing success.
Part of the content is taken from The Motley Fool.
Adria Cimino $Ocugen (OCGN.US)$ : Ocugen surged more than 700% in a matter of weeks earlier this year on optimism about potential coronavirus vaccine sales. The biotech company partnered with Bharat Biotech to co-commercialize that company's vaccine -- Covaxin -- in the U.S. The deal later expanded to include Canada. But Ocugen has struggled to actually bring Covaxin to market. As a result, shares have dropped 68% from their peak back in February.
Pfizer: Something to attract nearly every investor
Keith Speights $Pfizer (PFE.US)$ : If you're an income-seeking investor, Pfizer is a no-brainer choice over Ocugen. The big drugmaker's dividend currently yields 2.7%. It's a pretty safe bet that Pfizer will increase its dividends for years to come. Ocugen, of course, doesn't make enough money to pay a dividend.
Ocugen or Pfizer?
Your choice may depend on your investing style. An investor looking for a chance at steep gains fast may go for Ocugen. But as Keith says, the risk is that such a stock also may suffer big losses. Overall, Pfizer represents an opportunity to grow your investment over time -- and expose yourself to a lot less risk. In general, that's always a better recipe for long-term investing success.
Part of the content is taken from The Motley Fool.
20
1
MrMike
voted
if thats something you want to see, slap a yes on this survey. If you haveenoufh to work with already or simply dont want to see another Officer Truth post today,I get it lol
ill close the poll at 3pm est
$Advanced Health Intelligence Ltd (AHI.AU)$ $Apple (AAPL.US)$ $SPDR S&P 500 ETF (SPY.US)$ $Ocugen (OCGN.US)$ $Exela Technologies (XELA.US)$ $Bed Bath & Beyond Inc (BBBY.US)$
ill close the poll at 3pm est
$Advanced Health Intelligence Ltd (AHI.AU)$ $Apple (AAPL.US)$ $SPDR S&P 500 ETF (SPY.US)$ $Ocugen (OCGN.US)$ $Exela Technologies (XELA.US)$ $Bed Bath & Beyond Inc (BBBY.US)$
28
2
MrMike
liked
MrMike
reacted to
$Ocugen (OCGN.US)$ what to do
8
2
MrMike
liked
$Ocugen (OCGN.US)$ Why does OCGN seem like crap?
Translated
9
2
MrMike
liked
$Ocugen (OCGN.US)$ Already at the bottom, you can start buying
Translated
8
1